medigraphic.com
ISSN 1561-2945 (Print)

2014, Number 3

<< Back Next >>

Revista Cubana de Cirugía 2014; 53 (3)

Mortality from malignant brain tumors within the first 30 days after surgery

Solomon CMT, Roig FE, Pila BM, Domínguez W, Crombet RT

Language: Spanish
References: 30
Page: 244-255
PDF size: 164.99 Kb.


ABSTRACT

Introduction: The neurological complications found in the high gradegliomas surgery are primarily related with location, exposure and extension of the resection and with the way of handling tissues. There are secondary factors that contribute to the unfavorable progression and even the early death of patients that suffers this disease.
Objectives: To set the relationship between mortality within the first 30 days after surgery and the different risk factors, and to identify the causes of death.
Methods: One hundred and thirty one patients diagnosed with high gradegliomas were operated on in the neurosurgery service of "Calixto García" hospital from January 2005 through January 2010. Fourteen of them died within the first thirty days. The study variables were age, tumor location, degree of surgical resection and causes of death. Chi-square test of independence with significance level of 0.05 was applied to evaluate the association among the variables.
Results: The perioperative mortality rate was 10.7 %. The risk of death was higher in males; slightly higher in those over 60 years and unrelated to the tumor location. If patients are operated on with signs of brain herniation, they are more likely to die in the first month. Partial compared to total resection and to biopsy showed higher mortality probabilities. There was no intraoperative death.
Conclusions: The low scoring in the Karnofsky Scale, and a partial resection equal or smaller than 50 % in a craniotomy were the influential factors in an unfavorable outcome of disease.


REFERENCES

  1. Bruch HP, Schwadner O. Patient anxiety before surgery. Anasthesiol Intensivmed. 1997;32:S315-S317.

  2. Erba G, Moja L, Beghi E, Messina P, Pupillo E. Barries toward epilepsy surgery. A survey among practicing neurologist. Epilepsia. 2012;53(1):35-43.

  3. Glance LG, Osler TM, Mukamel DB, Dick AW. Impact of the present-on-admission indicator on hospital quality measurement: experience with the Agency for Health care Research and Quality (AHRQ) Inpatient Quality Indicators. Med Care. 2008;46:112-9.

  4. Fecho K, Lunney AT, Boysen PG, Rock P, Norfleet EA. Postoperative mortality after in patient surgery: incidence and risk factors. Ther Clin Risk Manag. 2008;4:681-8.

  5. Karnofsky DA, Burchenal JH. The Clinical Evaluation of Chemotherapeutic Agents in Cancer. In: MacLeod CM (Ed). Evaluation of Chemotherapeutic Agents. Columbia: Univ Press; 1949. p. 196.

  6. Grant R, Metcalfe SE. Biopsia versus resección para el glioma maligno (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2008 Número 4. Oxford: Update Software Ltd. Disponible en: http://www.update-oftware.com (Traducida de The Cochrane Library, 2008 Issue 3. Chichester, UK: John Wiley & Sons, Ltd.). [Citado abril 2014]

  7. Kleihues P, Burger PC, Scheithauer BW. The New WHO classification of brain tumors. Brain Pathol. 1993;3:255-68.

  8. Moiyadi AV, M Shetty P. Perioperative outcomes following surgery for brain tumors: Objective assessment and risk factor evaluation. J Neurosci Rural Pract. 2012 Jan- Apr;3(1):28-35.

  9. Solheim O, Jakola AS, Gulati S, Johannesen TB. Incidence and causes of perioperative mortality after primary surgery for intracranial tumors: a national, population- based study. J Neurosurg. 2012;116:825-34.

  10. Fadul C, Wood J, Thaler H, Galicich J, Patterson RH Jr, Posner JB. Morbidity and mortality of craniotomy for excision of supratentoria lgliomas. Neurology. 1988;38(9):1374-9.

  11. Rabadán AT, Hernandez D, Eleta M, Pietrani M, Baccanelli M, Christiansen S, et al. Factors related to surgical complications and their impact on the functional status in 236 open surgeries for malignant tumors in a Latin-American hospital. Surg Neurol. 2007 Oct;68(4):412-20;discussion 420.

  12. Sawaya R, Hammoud M, Schoppa D, Hess KR, Wu SZ, Shi WM, et al. Neurosurgical Out comes in a Modern Series of 400 Craniotomies for Treatment of Parenchymal Tumors. Neurosurgery. 1998;42(5):1044-55.

  13. Brell M, Ibáñez J, Caral L, Ferrer E. Factors influencing surgical complications of intra-axial brain tumours. Acta Neurochir (Wien). 2000;142(7):739-50.

  14. Sanai N, Berger MS. Mapping the horizon: techniques to optimize tumor resection before and during surgery. Clin Neurosurg. 2008;55:14-9. PubMed-indexedfor MEDLINE.

  15. Chaichana KL, Garzon-Muvdi T, Parker S, Weingart JD, Olivi A, Bennett R, et al. Supratentorial glioblastoma multiforme: the role of surgical resection versus biopsy among older patients. Ann Surg Oncol. 2011 Jan;18(1):239-45.

  16. Ammirati M, Vick N, Liao YL, Ciric I, Mikhael M. Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and an aplastic astrocytomas. Neurosurgery. 1987 Aug 1;21(2):201-6.

  17. Ciric I, Weinsweig D. Internal Decompression of Intra-axial Supratentorial Tumors (Malignant Supratentorial Gliomas and Metastatic Tumors). En: Apuzzo M. Brain Surgery: Complication Avoidance and Management. 3ra. Ed. New York: Churchill Livingstone; 1993. p. 431-42.

  18. Chang SM, Parney IF, McDermott M, Barker FG, Schmidt MH, Huang W, et al. Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg. 2003 Jun;98(6):1175-81.

  19. Ciric I, Ammirati M, and Vick M. Supratentorial gliomas: surgical considerations and immediate postoperative results. Gross total resection versus partial resection. Neurosurgery. 1987;21:21-6.

  20. Vecht CJ, Avezaat CJ, van Putten WL, Eijkenboom WM, Stefanko SZ. The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients. J Neurol Neurosurg Psychiatry. 1990 Jun;53(6):466-71.

  21. Hall WA. The Safety and Efficacy of Stereotactic Biopsy for Intracranial Lesions. Cancer. 1998;82(9):1749-55.

  22. Teixidor P, García R, Alamar M, González M, Llasera R, Durá MJ, et al. Complicaciones intraoperatorias del mapeo corticosubcortical. Neurocirugía. 2010;21:99-107.

  23. Mery F, Zarate A, Fadic R, Lorenzoni J, Elgueta F, Villanueva P, et al. Resección de lesiones cerebrales con asistencia de mapeo cortical intra operatorio. Rev Chil Neuropsiquiat. 2010;48(3):184-96.

  24. Choudhari KA. Commentary: Surgery for glioblastoma and influence of technology on outcomes between developed and developing parts of the world. Surg Neurol. 2010;73(2):200-16.

  25. Picht T, Kombos T, Gramm HJ, Brock M, Suess O. Multimodal protocol for awake craniotomy in language cortex tumor surgery. Acta Neuro chir (Wien). 2006;148:127-38.

  26. Serletis D, Bernstein M. Prospective study of awake craniotomy used routinely and non selectively for supratentorial tumors. J Neurosurg. 2007;107:1-6.

  27. Kawashima Y, Takahashi S, Suzuki M, Morita K, Irita K, et al. Anesthesia-related mortality and morbidity over a 5-year period in 2,363,038 patients in Japan. Acta Anaesthesiol Scand. 2003;47:809-17.

  28. Lassen B, Helseth E, Ronning P, Scheie D, Johannesen TB, Mæhlen J, et al. Surgical Mortality at 30 Days and Complications Leading to Recraniotomy in 2630 Consecutive Craniotomies for Intracranial Tumors. Neurosurgery. 2011 May;68(5):1259-68;discussion 1268-9.

  29. Salcman M. Supratentorialgliomas: Clinical features and surgical therapy. En: Wilkins H. R, Rengachary SS (Eds.) Neurosurgery. 2nd. edition. vol 1. New York: McGraw-Hill Book Co.; 1996. p. 777-8.

  30. Dimick JB, Welch HG, Birkmeyer JD. Surgical mortality as an indicator of hospital quality: the problem with small sample size. JAMA. 2004;92:847-51.




2020     |     www.medigraphic.com